193 related articles for article (PubMed ID: 35513479)
1. Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion.
Goodson N; Wicks P; Morgan J; Hashem L; Callinan S; Reites J
NPJ Digit Med; 2022 May; 5(1):58. PubMed ID: 35513479
[TBL] [Abstract][Full Text] [Related]
2. Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective.
de Jong AJ; Shahid N; Zuidgeest MGP; Santa-Ana-Tellez Y; Hogervorst M; Goettsch W; Traore H; de Boer A; Gardarsdottir H;
Value Health; 2024 Mar; 27(3):294-300. PubMed ID: 38043711
[TBL] [Abstract][Full Text] [Related]
3. A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs).
Coyle J; Rogers A; Copland R; De Paoli G; MacDonald TM; Mackenzie IS;
Trials; 2022 Jul; 23(1):614. PubMed ID: 35907888
[TBL] [Abstract][Full Text] [Related]
4. Decentralized clinical trials (DCTs): A few ethical considerations.
Petrini C; Mannelli C; Riva L; Gainotti S; Gussoni G
Front Public Health; 2022; 10():1081150. PubMed ID: 36590004
[TBL] [Abstract][Full Text] [Related]
5. Decentralized Clinical Trials in the Development of Drugs and Biological Products.
Robinson R; Sacks L
Ther Innov Regul Sci; 2024 Feb; ():. PubMed ID: 38305983
[TBL] [Abstract][Full Text] [Related]
6. The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidance.
Park J; Huh KY; Chung WK; Yu KS
Transl Clin Pharmacol; 2024 Mar; 32(1):41-51. PubMed ID: 38586122
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Opportunities and challenges with decentralized trials in Neuroscience.
Burger HU; Van de Casteele T; Rantell KR; Corey-Lisle P; Sfikas N; Abt M;
Biom J; 2023 Dec; 65(8):e2200370. PubMed ID: 37609878
[TBL] [Abstract][Full Text] [Related]
9. Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned.
Hanley DF; Bernard GR; Wilkins CH; Selker HP; Dwyer JP; Dean JM; Benjamin DK; Dunsmore SE; Waddy SP; Wiley KL; Palm ME; Mould WA; Ford DF; Burr JS; Huvane J; Lane K; Poole L; Edwards TL; Kennedy N; Boone LR; Bell J; Serdoz E; Byrne LM; Harris PA
J Clin Transl Sci; 2023; 7(1):e170. PubMed ID: 37654775
[TBL] [Abstract][Full Text] [Related]
10. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.
Apostolaros M; Babaian D; Corneli A; Forrest A; Hamre G; Hewett J; Podolsky L; Popat V; Randall P
Ther Innov Regul Sci; 2020 Jul; 54(4):779-787. PubMed ID: 32557302
[TBL] [Abstract][Full Text] [Related]
11. Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment.
Betcheva L; Kim JY; Erhun F; Oraiopoulos N; Getz K
Ther Innov Regul Sci; 2023 Sep; 57(5):1081-1098. PubMed ID: 37389795
[TBL] [Abstract][Full Text] [Related]
12. Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective.
Ghadessi M; Di J; Wang C; Toyoizumi K; Shao N; Mei C; Demanuele C; Tang RS; McMillan G; Beckman RA
Orphanet J Rare Dis; 2023 Apr; 18(1):79. PubMed ID: 37041605
[TBL] [Abstract][Full Text] [Related]
13. Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective.
de Jong AJ; van Rijssel TI; Zuidgeest MGP; van Thiel GJMW; Askin S; Fons-Martínez J; De Smedt T; de Boer A; Santa-Ana-Tellez Y; Gardarsdottir H;
Clin Pharmacol Ther; 2022 Aug; 112(2):344-352. PubMed ID: 35488483
[TBL] [Abstract][Full Text] [Related]
14. Involving South Asian patients in clinical trials.
Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
[TBL] [Abstract][Full Text] [Related]
15. The future of clinical trials-is it virtual?
Ng CE; Bowman S; Ling J; Bagshaw R; Birt A; Yiannakou Y
Br Med Bull; 2023 Dec; 148(1):42-57. PubMed ID: 37681298
[TBL] [Abstract][Full Text] [Related]
16. What role can decentralized trial designs play to improve rare disease studies?
Moore J; Goodson N; Wicks P; Reites J
Orphanet J Rare Dis; 2022 Jun; 17(1):240. PubMed ID: 35725484
[TBL] [Abstract][Full Text] [Related]
17. Decentralized Clinical Trials: Potentials for Equity in Digital Health.
Weber D; Nøhr C
Stud Health Technol Inform; 2023 Jun; 304():91-95. PubMed ID: 37347577
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
Sinclair P; Kable A; Levett-Jones T
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
[TBL] [Abstract][Full Text] [Related]
19. Assessing the Financial Value of Decentralized Clinical Trials.
DiMasi JA; Smith Z; Oakley-Girvan I; Mackinnon A; Costello M; Tenaerts P; Getz KA
Ther Innov Regul Sci; 2023 Mar; 57(2):209-219. PubMed ID: 36104654
[TBL] [Abstract][Full Text] [Related]
20. Strategies for research participant engagement: A synthetic review and conceptual framework.
Wong CA; Song WB; Jiao M; O'Brien E; Ubel P; Wang G; Scales CD
Clin Trials; 2021 Aug; 18(4):457-465. PubMed ID: 34011179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
